NIP
WGS icon

Nicholas Investment Partners’s GeneDx Holdings WGS Stock Holding History

Nicholas Investment Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-131,610
Closed -$11.7M – 232
2025
Q1 		$11.7M Buy
131,610
+34,561
+36% +$3M 1.2% 19
2024
Q4 		$7.46M Buy
97,049
+27,712
+40% +$1.94M 0.66% 46
2024
Q3 		$2.94M Buy
+69,337
New +$2.34M 0.27% 136

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Nicholas Investment Partners's WGS Position: Q2 2025 in Review

Nicholas Investment Partners sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 131,610 shares — an estimated $11.7M sold.

Nicholas Investment Partners first reported a position in WGS in Q3 2024 and held it in 3 quarters. The position peaked at $11.7M in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Nicholas Investment Partners reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Nicholas Investment Partners sold 131,610 GeneDx Holdings shares in Q2 2025, an estimated $11.7M.
  • Nicholas Investment Partners first reported a position in GeneDx Holdings in Q3 2024 and held it in 3 quarters.
  • Nicholas Investment Partners's GeneDx Holdings position peaked at $11.7M in Q1 2025.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Nicholas Investment Partners's 13F filing for Q2 2025, filed 14 Aug 2025.